Literature DB >> 12067293

Kinetics of changes in lymphocyte sub-populations in mouse lungs after intrapulmonary infection with M. bovis (Bacillus Calmette-Guerin) and identity of cells responsible for IFNgamma responses.

R K Saxena1, D Weissman, Q B Saxena, J Simpson, D M Lewis.   

Abstract

Gamma interferon (IFNgamma) plays a key role in host defense against pulmonary mycobacterial infections. A variety of lymphocyte subsets may participate in producing pulmonary IFNgamma responses, but their relative contributions after mycobacterial infection have not been clearly elucidated. To address this question, C57Bl/6 female mice were infected by intrapulmonary instillation of 2.5 x 104 BCG (Mycobacterium bovis Bacillus Calmette-Guerin). Lymphocyte populations in lung interstitium were examined at different time points after the infection. BCG load in lungs peaked between 4 and 6 weeks post-infection and declined to very low levels by the 12th week of infection. Recovery of lung interstitial lymphocytes doubled by 4-6 weeks after infection and declined thereafter. Flow cytometric analysis of the lung-derived lymphocytes revealed that about 5% of the these cells made IFNgamma in control mice, and this baseline IFNgamma production involved T (CD3+NK1.1-), NK (CD3-NK1.1+) and NKT (CD3+NK1.1+) cells. As the BCG lung infection peaked, the total number of CD3+ T cells in the lungs increased threefold at 5-6 weeks post-infection. There was a marked increase (sixfold) in the number of T cells secreting IFNgamma 5-6 weeks post-infection. Some increase was also noted in the NKT cells making IFNgamma, but the numbers of NK cells making IFNgamma in BCG-infected lungs remained unaltered. Our results suggest that whereas NK and NKT cells contribute to baseline IFNgamma secretion in control lungs, expansion in the IFNgamma-producing T-cell population was essentially responsible for the augmented response seen in lungs of BCG-infected mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067293      PMCID: PMC1906272          DOI: 10.1046/j.1365-2249.2002.01839.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Beyond BCG: the potential for a more effective TB vaccine.

Authors:  I M Orme
Journal:  Mol Med Today       Date:  1999-11

2.  Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guérin infection via augmentation of NK and T cytotoxic 1 responses.

Authors:  M Umemura; H Nishimura; K Hirose; T Matsuguchi; Y Yoshikai
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

Review 3.  The BCG story: lessons from the past and implications for the future.

Authors:  P E Fine
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

4.  Enhanced protection against fatal mycobacterial infection in SCID beige mice by reshaping innate immunity with IFN-gamma transgene.

Authors:  Z Xing; A Zganiacz; J Wang; S K Sharma
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Epidemiology of tuberculosis.

Authors:  G W Comstock
Journal:  Am Rev Respir Dis       Date:  1982-03

Review 6.  Dynamics and control of the global tuberculosis epidemic.

Authors:  D Bleed; C Dye; M C Raviglione
Journal:  Curr Opin Pulm Med       Date:  2000-05       Impact factor: 3.155

7.  Infection of mice with Mycobacterium bovis-BCG induces both Th1 and Th2 immune responses in the absence of interferon-gamma signalling.

Authors:  K J Erb; J Kirman; B Delahunt; H Moll; G Le Gros
Journal:  Eur Cytokine Netw       Date:  1999-06       Impact factor: 2.737

8.  Restraining mycobacteria: role of granulomas in mycobacterial infections.

Authors:  B M Saunders; A M Cooper
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

9.  Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.

Authors:  R H Wiltrout; R B Herberman; S R Zhang; M A Chirigos; J R Ortaldo; K M Green; J E Talmadge
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Characterization of inducible nitric oxide synthase expression in human airway epithelium.

Authors:  F H Guo; S C Erzurum
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

View more
  4 in total

1.  Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  John Kuchtey; Scott A Fulton; Scott M Reba; Clifford V Harding; W Henry Boom
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Relative efficacy of uptake and presentation of Mycobacterium bovis BCG antigens by type I mouse lung epithelial cells and peritoneal macrophages.

Authors:  Mandavi Kumari; Rajiv K Saxena
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

3.  Pathogen-related differences in the abundance of presented antigen are reflected in CD4+ T cell dynamic behavior and effector function in the lung.

Authors:  Parizad Torabi-Parizi; Nienke Vrisekoop; Wolfgang Kastenmuller; Michael Y Gerner; Jackson G Egen; Ronald N Germain
Journal:  J Immunol       Date:  2014-01-15       Impact factor: 5.422

Review 4.  Natural killer cells in infection and inflammation of the lung.

Authors:  Fiona J Culley
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.